Olokizumab reduces the risks of death in hospitalized patients with moderate and severe COVID-19
Tavlueva, E.V., Markarov, A.E., Petrushin, M.A., Vizel, A.A., Ignatova, G.L., Antonov, V.N., Agaf'ina, A.S., Bakirov, B.A., Mozgovaya, V.M., Filon, O.V., Zinkovskaya, A.V., Dolgorukova, A.N., Samsonov, M.Yu
Published in Infectious diseases: News, Opinions, Training (2022)
Published in Infectious diseases: News, Opinions, Training (2022)
Get full text
Journal Article